University of Melbourne licenses radionuclide technology to Telix
- Radiopharmaceuticals, Contrast Agents
- R+D and Marketing-Licensing
- Includes Royalty or Profit Split Information
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.